Trial intelligence / Profile preview

Decapeptyl SR plus Livial for chronic cyclical pelvic pain

ISRCTN19040577Phase 4Completed

Sponsor
Sheffield Teaching Hospitals NHS Foundation Trust
Start
Dec 2008
Modality
Small Molecules, Peptides, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
01

Overview

Phase 4, open-label, single-arm trial of triptorelin and tibolone in chronic prostatitis (CP) and endometriosis, sponsored by Sheffield Teaching Hospitals NHS Foundation Trust. Primary endpoint: Impact of Decapeptyl SR plus tibolone on chronic cyclical pelvic pain over 24 months. Started Dec 2008; status: completed.

02

Drugs

triptorelintibolone
03

Conditions

chronic prostatitis (CP)endometriosis

Beyond the preview

Go deeper on ISRCTN19040577.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ISRCTN19040577.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call